Abstract:Molecular imaging in the second near-infrared window (NIR-II) provides high-fidelity visualization of biopathological events in deep tissue. However, most NIR-II probes produce "always-on" output and demonstrate poor signal specificity toward biomarkers. Herein, we report a series of hemicyanine reporters (HBCs) with tunable emission to NIR-II window (715-1188 nm) and structurally amenable to constructing activatable probes. Such manipulation of emission wavelengths relies on rational molecular engineering by integrating benz[c,d]indolium, benzo[b]xanthonium, and thiophene moieties to a conventional hemicyanine skeleton. In particular, HBC4 and HBC5 possess bright and record long emission over 1050 nm, enabling improved tissue penetration depth and superior signal to background ratio for intestinal tract mapping than NIR-I fluorophore HC1. An activatable inflammatory reporter (AIR-PE) is further constructed for pH-triggered site-specific release in colon. Due to minimized background interference, oral gavage of AIR-PE allows clear delineation of irritated intestines and assessment of therapeutic responses in a mouse model of inflammatory bowel disease (IBD) through real-time NIRF-II imaging. Benefiting from its high fecal clearance efficiency (>90%), AIR-PE can also detect IBD and evaluate the effectiveness of colitis treatments via in vitro optical fecalysis, which outperforms typical clinical assays including fecal occult blood testing and histological examination. This study thus presents NIR-II molecular scaffolds that are not only applicable to developing versatile activatable probes for early diagnosis and prognostic monitoring of deeply seated diseases but also hold promise for future clinical translations.

A Novel Near-Infrared Fluorescent Probe for Monitoring Cyclooxygenase-2 in Inflammation and Tumor

Sensing and Imaging Agents for Cyclooxygenase Enzyme

Lessons from Oregon in Embracing Complexity in End-of-Life Care.

Near‐Infrared Fluorescent Heptamethine Cyanine Dyes for COX‐2 Targeted Photodynamic Cancer Therapy

A Tumor-Targeting and Polarity-Specific Near-Infrared Fluorescent Probe for Accurate Cancer Diagnosis in Vivo

A novel near-infrared theranostic probe for accurate cancer chemotherapy <i>in vivo</i> by a dual activation strategy

The construction of a near-infrared fluorescent probe with dual advantages for imaging carbon monoxide in cells and <i>in vivo</i>

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update

A COX2-targeting cancer-specific fluorescent probe for hydrogen sulfide detection in living cells, Caenorhabditis elegans , and zebrafish

A Near-Infrared Fluorescence Probe with a Large Stokes Shift for Detecting Carbon Monoxide in Living Cells and Mice

Near-infrared Fluorescence Probe with a Large Stokes Shift for Visualizing Hydrogen Peroxide in Ulcerative Colitis Mice

Lysosome-Specific Coumarin-Based Fluorescent Bioprobes for in Vivo Polarity Sensing and Cancer Treatment

A Novel Precipitating-Fluorochrome-based Fluorescent Probe for Monitoring Carbon Monoxide During Drug-Induced Liver Injury.

Integrin-targeting Block Copolymer Probes for Two-Photon Fluorescence Bioimaging.

A Nitrobenzoxadiazole-Based Near-Infrared Fluorescent Probe for the Specific Imaging of H2S in Inflammatory and Tumor Mice.

One‐Pot Synthesis of Coumarin–Indomethacin Hybrids as COX‐2 Targeting Probes for Cancer Imaging

Disaggregation-Activated pan-COX Imaging Agents for Human Soft tissue Sarcoma

Ibuprofen-derived fluorescence inhibitor of COX-2 for breast cancer imaging, prevention and treatment

Rational Design of a Turn-on Near-Infrared Fluorescence Probe for the Highly Sensitive and Selective Monitoring of Carboxylesterase 2 in Living Systems.

In Situ Target Enzyme-Activated Near-Infrared Fluorescent Probe: A Case Study of CYP2J2 Using Three-Fragmentary Molecular Assembly Engineering

Molecular Engineering of Activatable NIR-II Hemicyanine Reporters for Early Diagnosis and Prognostic Assessment of Inflammatory Bowel Disease